PharmacoEconomics
Latest Publications

TOTAL DOCUMENTS

3629

(FIVE YEARS 352)

H-INDEX

95

(FIVE YEARS 9)

Published By Springer-Verlag

1179-2027, 1170-7690

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia

PharmacoEconomics ◽

10.1007/s40273-021-01127-1 ◽

2022 ◽

Author(s):

Kaitlyn Hastings ◽

Clara Marquina ◽

Jedidiah Morton ◽

Dina Abushanab ◽

Danielle Berkovic ◽

...

Keyword(s):

Cardiovascular Disease ◽

Socioeconomic Group ◽

Download Full-text

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

PharmacoEconomics ◽

10.1007/s40273-021-01112-8 ◽

2022 ◽

Author(s):

Don Husereau ◽

Michael Drummond ◽

Federico Augustovski ◽

Esther de Bekker-Grob ◽

Andrew H. Briggs ◽

...

Keyword(s):

Health Economic ◽

Economic Evaluation ◽

Health Economic Evaluation ◽

Economic Evaluations ◽

Reporting Standards

Download Full-text

Calibrating Natural History of Cancer Models in the Presence of Data Incompatibility: Problems and Solutions

PharmacoEconomics ◽

10.1007/s40273-021-01125-3 ◽

2022 ◽

Author(s):

Olena Mandrik ◽

Chloe Thomas ◽

Sophie Whyte ◽

James Chilcott

Keyword(s):

Natural History ◽

Cancer Models ◽

Problems And Solutions ◽

History Of Cancer

Download Full-text

Dramatic Innovations in the Treatment of Spinal Muscular Atrophy, But Many Unknowns Remain

PharmacoEconomics ◽

10.1007/s40273-021-01119-1 ◽

2021 ◽

Author(s):

Chris Skedgel

Keyword(s):

Spinal Muscular Atrophy ◽

Muscular Atrophy

Download Full-text

Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom

PharmacoEconomics ◽

10.1007/s40273-021-01106-6 ◽

2021 ◽

Author(s):

Timothy Spelman ◽

William L. Herring ◽

Yuanhui Zhang ◽

Michael Tempest ◽

Isobel Pearson ◽

...

Keyword(s):

Multiple Sclerosis ◽

United Kingdom ◽

Cost Effectiveness ◽

Comparative Effectiveness ◽

Inadequate Response ◽

The United Kingdom ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

Relapsing Remitting Multiple Sclerosis

Download Full-text

CHEERS to 30 Years of PharmacoEconomics

PharmacoEconomics ◽

10.1007/s40273-021-01111-9 ◽

2021 ◽

Author(s):

Richard Milne ◽

Christopher Carswell

Download Full-text

Importance of Patient Involvement in the Value Assessment Process: On the Way Towards Personalised Treatments

PharmacoEconomics ◽

10.1007/s40273-021-01122-6 ◽

2021 ◽

Author(s):

Nicole Gusset

Keyword(s):

Patient Involvement ◽

Assessment Process ◽

Value Assessment ◽

Download Full-text

Four Aspects Affecting Health Economic Decision Models and Their Validation

PharmacoEconomics ◽

10.1007/s40273-021-01110-w ◽

2021 ◽

Author(s):

Talitha Feenstra ◽

Isaac Corro-Ramos ◽

Dominique Hamerlijnck ◽

George van Voorn ◽

Salah Ghabri

Keyword(s):

Health Economic ◽

Decision Models ◽

Economic Decision

Download Full-text

In Absence of Absenteeism: Some Thoughts on Productivity Costs in Economic Evaluations in a Post-corona Era

PharmacoEconomics ◽

10.1007/s40273-021-01117-3 ◽

2021 ◽

Author(s):

Werner Brouwer ◽

Samare Huls ◽

Ayesha Sajjad ◽

Tim Kanters ◽

Leona Hakkaart-van Roijen ◽

...

Keyword(s):

Economic Evaluations ◽

Productivity Costs

Download Full-text

Deprescribing Interventions among Community-Dwelling Older Adults: A Systematic Review of Economic Evaluations

PharmacoEconomics ◽

10.1007/s40273-021-01120-8 ◽

2021 ◽

Author(s):

Sónia Romano ◽

Débora Figueira ◽

Inês Teixeira ◽

Julian Perelman

Keyword(s):

Systematic Review ◽

Older Adults ◽

Community Dwelling ◽

Economic Evaluations ◽

Community Dwelling Older Adults

Download Full-text